Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Enhancing Treatment of Hepatitis C in Opioid Substitution Settings II (ETHOS II): A Partnership Project to Enhance Hepatitis C Care in Drug and Alcohol Clinics

NCT03685045 is registered in ClinicalTrials.gov with Kirby Institute as lead sponsor.

NCT NCT03685045
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03685045 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Enhancing Treatment of Hepatitis C in Opioid Substitution Settings II (ETHOS II): A Partnership Project to Enhance Hepatitis C Care in Drug and Alcohol Clinics
Lead sponsor
Kirby Institute
Phase
Not applicable
Overall status
Recruiting
Start date
May 28, 2018
Completion date
December 31, 2028
Enrollment
6,000 (estimated)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c